RxDoctor Payments Data

Michael Loshigian, DPM

Podiatrist · Fresh Meadows, NYNPI 1235139106

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,169 of the $6,369 with a category attached, or 81.2%. 24 manufacturers reported payments, led by Stryker at 55.4% of the total. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,369in general payments, 2019–2025

Across 89 payments — averaging $71.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Treace Medical Concepts, Inc.$541
  • Bioventus LLC$160
  • AbbVie$143
  • Paratek Pharmaceuticals, Inc.$136
  • plus $659 from 18 others

What the payments were for

  • Food & beverage$5,16981%
  • Education$1,20019%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,369 in reported general payments places this provider in the 90th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$168,825
Medicare patients
480
Services billed
1,923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium20$5,427
Nystatin292$4,560
Ammonium Lactate26$539
Fluconazole36$536
Mupirocin43$395
Terbinafine Hcl62$350
Gabapentin33$283
Meloxicam44$176
Cefadroxil15$116

Paid to pharmacies, not to this prescriber.

Other podiatrist in Fresh Meadows

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →